-
Centrum Broking has a 'buy' call for 10 out of the 12 chemicals and agrochemicals players under its coverage.
-
Taking the cue from the government’s roadmap for ethanol blending with petrol, many sugar manufacturers have already lined up the significant expansion of the renewable fuel.
-
The primary risk of COVID has re-surfaced again which will prompt the RBI to keep an accommodative stance in the April meet and ensure any premature withdrawal of liquidity doesn’t send a wrong message to the market, says Maheshwari.
-
All five ideas that are showcased in the current top picks from Centrum Broking note are a reflection of their investment philosophy
-
Centrum recommended hold rating on Swaraj Engines with a target price of Rs 2183 in its research report dated November 01, 2017.
-
Centrum is bullish on GIC Housing Finance has recommended hold rating on the stock with a target price of Rs 530 in its research report dated 05 September 2017.
-
Centrum is bullish on FIEM Industries has recommended buy rating on the stock with a target price of Rs 1260 in its research report dated 06 September 2017.
-
-
Centrum is bullish on Karnataka Bank has recommended buy rating on the stock with a target price of Rs 170 in its research report dated March 29, 2017.
-
Centrum Broking is bearish on Petronet LNG has recommended sell rating on the stock with a target price of Rs 256 in its research report dated September 06, 2016.
-
Centrum Broking is bullish on MRPL has recommended buy rating on the stock with a target price of Rs 97 in its research report dated September 06, 2016.
-
While many upgrades are happening post earnings, downgrades are still visible especially in the banking sector, says Dipankar Choudhury of Centrum Broking.
-
In an interview with CNBC-TV18, Madhu Babu of Centrum Broking said mid-cap IT segment will grow 12-13 percent in the current quarter.
-
Vinay Pandit, Sr VP-Institutional Equities at Centrum Broking is of the view that Apar Industries may rise nad hit Rs 490.
-
Vinay Pandit, Sr VP-Institutional Equities at Centrum Broking is of the view that IFB Industries may hit Rs 780.
-
Vinay Pandit, Sr VP-Institutional Equities at Centrum Broking is of the view that MRPL may test Rs 104.
-
Vinay Pandit of Centrum Broking is not expecting any major downside in the market from the current levels of around 8300.
-
More than 50 companies are expected to participate in the one-day Centrum Investor Conference on May 29 in Mumbai.
-
What also works in favour of the company is cement price which is atleast Rs 20 per bag higher in the core NE markets than those in West Bengal. Significant state thrust on roads and hydro power projects offers long-term cement demand potential of 15 percent CAGR.
-
Abhisar Jain, senior vice president- metals & mining, Centrum Broking says overcapacity in China is hitting global steel prices and hence prices are likely to correct even further.
-
In an interview to CNBC-TV18, Ravi Menon, AVP - IT, Centrum Broking, Vibhor Singhal, IT Analyst, Phillip Capital and Sarabjit Kaur Nangra, VP - Research Pharma, Angel Broking spoke about Wipro‘s financial performance in the quarter gone by and the road ahead.
-
Analysts at Motilal Oswal believe that Lupin, Ranbaxy, Cadila Healthcare, GSK Pharma, Torrent Pharma and Alembic Pharma will report stronger overall operational performance during this quarter.
-
In an interview to CNBC-TV18, Ravi Menon, I-T Analyst at Centrum Broking, discusses the the deal pipeline of the IT companies and how the sector is poised to move going ahead.
-
Ranjit Kapadia, pharma analyst of Centrum Broking suggests selling Ranbaxy Laboratories with a target Rs 270.
-
Pfizer East India B.V. Netherlands will buy a 29.52 percent stake in Pfizer Ltd from Pfizer Investments Netherlands B.V's for Rs 1,537 a share.
